title: Sputum eosinophilia: an early marker of bronchial response to occupational agents.
abstract: BACKGROUND
  False-negative responses to specific inhalation challenge (SIC) with occupational agents may occur. We explored whether assessing changes in sputum cell counts would help improve the identification of bronchial reactivity to occupational agents during SICs.
  
  
  METHODS
  The predictive value of the changes in sputum cell counts after a negative FEV(1) response to a first challenge exposure to an occupational agent was determined using the changes in airway calibre observed during repeated challenges as the 'gold standard'. The study included 68 subjects investigated for work-related asthma in a tertiary centre. After a control day, the subjects were challenged with the suspected occupational agent(s) for up to 2 h. All subjects who did not show an asthmatic reaction were re-challenged on the following day. Additional challenges were proposed to those who demonstrated a > or = 2% increase in sputum eosinophils or an increase in nonspecific bronchial hyperresponsiveness to histamine after the second challenge day.
  
  
  RESULTS
  Six of the 35 subjects without changes in FEV(1) on the first challenge developed an asthmatic reaction on subsequent challenges. ROC analysis revealed that a >3% increase in sputum eosinophils at the end of the first challenge day was the most accurate parameter for predicting the development of an asthmatic response on subsequent challenges with a sensitivity of 67% and a specificity of 97%.
  
  
  CONCLUSIONS
  An increase in sputum eosinophils is an early marker of specific bronchial reactivity to occupational agents, which may help to identify subjects who will develop an asthmatic reaction only after repeated exposure.
authors.affiliation: Department of Chest Medicine, Mont-Godinne Hospital, Université Catholique de Louvain, Yvoir, Belgium.
authors.forename: O
authors.initials: O
authors.lastname: Vandenplas
authors.forename: V
authors.initials: V
authors.lastname: D'Alpaos
authors.forename: J
authors.initials: J
authors.lastname: Heymans
authors.forename: J
authors.initials: J
authors.lastname: Jamart
authors.forename: J
authors.initials: J
authors.lastname: Thimpont
authors.forename: F
authors.initials: F
authors.lastname: Huaux
authors.forename: D
authors.initials: D
authors.lastname: Lison
authors.forename: J-C
authors.initials: JC
authors.lastname: Renauld
mesh_terms: D000328:Adult; D000485:Allergens / Q000276:immunology; D001249:Asthma / Q000175:diagnosis* / Q000276:immunology; D015415:Biomarkers; D001985:Bronchial Provocation Tests; D004802:Eosinophilia / Q000175:diagnosis* / Q000276:immunology; D004804:Eosinophils / Q000276:immunology*; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009784:Occupational Diseases / Q000175:diagnosis* / Q000276:immunology; D016273:Occupational Exposure; D012129:Respiratory Function Tests; D013147:Spirometry; D013183:Sputum / Q000166:cytology / Q000276:immunology*
chemical_list: D000485:Allergens; D015415:Biomarkers